Q32 Bio, Inc. (QTTB)
16.36
+0.39
(+2.44%)
USD |
NASDAQ |
Aug 24, 16:00
16.34
-0.02
(-0.12%)
After-Hours: 20:00
Q32 Bio Market Cap : 388.33M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 388.33M |
| August 21, 2026 | 379.07M |
| August 20, 2026 | 376.46M |
| August 19, 2026 | 375.99M |
| August 18, 2026 | 362.93M |
| August 17, 2026 | 378.60M |
| August 14, 2026 | 359.61M |
| August 13, 2026 | 364.83M |
| August 12, 2026 | 364.83M |
| August 11, 2026 | 365.78M |
| August 10, 2026 | 371.95M |
| August 07, 2026 | 370.29M |
| August 06, 2026 | 384.53M |
| August 05, 2026 | 391.42M |
| August 04, 2026 | 383.46M |
| August 03, 2026 | 359.97M |
| July 31, 2026 | 229.39M |
| July 30, 2026 | 227.64M |
| July 29, 2026 | 214.18M |
| July 28, 2026 | 229.83M |
| July 27, 2026 | 222.51M |
| July 24, 2026 | 221.64M |
| July 23, 2026 | 225.00M |
| July 22, 2026 | 220.61M |
| July 21, 2026 | 225.44M |
| Date | Value |
|---|---|
| July 20, 2026 | 220.03M |
| July 17, 2026 | 220.17M |
| July 16, 2026 | 222.51M |
| July 15, 2026 | 229.68M |
| July 14, 2026 | 270.06M |
| July 13, 2026 | 312.78M |
| July 10, 2026 | 164.00M |
| July 09, 2026 | 184.19M |
| July 08, 2026 | 205.98M |
| July 07, 2026 | 199.25M |
| July 06, 2026 | 188.21M |
| July 02, 2026 | 191.50M |
| July 01, 2026 | 184.33M |
| June 30, 2026 | 186.38M |
| June 29, 2026 | 206.86M |
| June 26, 2026 | 192.67M |
| June 25, 2026 | 174.82M |
| June 24, 2026 | 163.27M |
| June 23, 2026 | 173.80M |
| June 22, 2026 | 185.06M |
| June 18, 2026 | 174.09M |
| June 17, 2026 | 188.87M |
| June 16, 2026 | 186.53M |
| June 15, 2026 | 188.14M |
| June 12, 2026 | 184.92M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rallybio Corp. | 89.16M |
| Beam Therapeutics, Inc. | 2.925B |
| C4 Therapeutics, Inc. | 503.91M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.21M |
Market Cap Related Metrics
| PE Ratio | 5.451 |
| PS Ratio | 4.511 |
| Price to Book Value | 3.667 |
| Price | 16.36 |
| Earnings Yield | 18.35% |
| Operating PE Ratio | 11.30 |
| Normalized PE Ratio | 5.442 |